500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Honore, Patrick M.
Barret Gutierrez, Leonel
De Bels, David
Text and Data Mining valid from 2020-12-01
Version of Record valid from 2020-12-03
17 August 2020
21 November 2020
3 December 2020
Ethics approval and consent to participate
The authors declare to have no competing interests.